TG and ischemia: One possible reason for this superiority may be that lower serum levels of FT3, as the unbound and biologically active form of thyroid hormone, have been reported to be negatively associated with neuroprotection for ischemia and the serotoninergic neurotransmitter system (Taroza et al., 2019), which could increase the risk of PSD development.